Trial Profile
A multicenter, non-interventional study evaluating adherence and tolerability of prolonged-release tacrolimus (Advagraf ) in kidney transplant patients in Germany
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Oct 2017
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Graft-versus-host disease
- Focus Adverse reactions; Therapeutic Use
- Acronyms COMET
- 30 Oct 2017 New trial record
- 20 Oct 2017 Results published in the Clinical Transplantation